We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HEXT:NSEHexaware Technologies Limited Analysis

Data as of 2026-05-18 - not real-time

₹486.95

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Hexaware Technologies posted a solid 12.6% revenue growth with a healthy gross margin of ~41% and an ROE above 22%, underpinned by a strong cash position (≈₹20.9 bn) and a modest debt‑to‑equity ratio (~10.5%). The forward EPS outlook (₹27.37) and a forward P/E near 18x are well below the industry average P/E of ~38x, while the current price (~₹487) sits below both the DCF‑derived fair value (~₹763) and analyst median target (~₹528), indicating ~9% upside. Technicals are supportive – the MACD is bullish, RSI is neutral at 56, and volume is trending higher – and the dividend yield of ~2.9% with a 51% payout ratio appears sustainable.
The company’s AI‑native platforms (Amaze, Tensai, RapidX, Agentverse) and expanding service footprint across high‑growth sectors provide a credible growth narrative. Risk is mitigated by a low beta (~0.67) and a diversified geographic client base, though 30‑day volatility remains elevated (~37%). Overall, the fundamentals, valuation gap, and positive technical momentum suggest a compelling buying opportunity.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD crossover with rising volume
  • Current price comfortably above support and below resistance
  • Strong cash flow supporting dividend sustainability

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Valuation upside of ~9% to analyst median target
  • Revenue growth driven by AI‑native service platforms
  • Forward earnings visibility and lower forward P/E versus peers

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • DCF fair value suggests significant long‑run upside
  • Robust balance sheet with low leverage and high free cash flow
  • Exposure to global macro‑economic cycles and regulatory environment

Key Metrics & Analysis

Financial Health

Revenue Growth12.60%
Profit Margin10.07%
P/E Ratio21.6
ROE22.27%
ROA11.22%
Debt/Equity10.52
P/B Ratio4.4
Op. Cash Flow₹17.4B
Free Cash Flow₹20.2B
Industry P/E38.6

Technical Analysis

TrendNeutral
RSI56.1
Support₹443.15
Resistance₹507.00
MA 20₹470.23
MA 50₹457.33
MA 200₹647.96
MACDBullish
VolumeIncreasing
Fear & Greed Index88.05

Valuation

Fair Value₹763.30
Target Price₹531.25
Upside/Downside9.10%
GradeUndervalued
TypeBlend
Dividend Yield2.94%

Risk Assessment

Beta0.67
Volatility37.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.